Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model. https://t.co/lD18UXLvtz
1,219 followers
1,911 followers
RT @BloodAdvances: BTZ triggers viral replication in the tumor microenvironment enhancing anticancer cytotoxic and immune modulatory signal…
31,753 followers
BTZ triggers viral replication in the tumor microenvironment enhancing anticancer cytotoxic and immune modulatory signals. https://t.co/tRp3cCpXlb #Immunobiology #Immunotherapy #LymphoidNeoplasia https://t.co/BQPmRVegPh
1,111 followers
RT @BloodAdvances: Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model #…